CN102579753A - Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery - Google Patents
Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery Download PDFInfo
- Publication number
- CN102579753A CN102579753A CN2011100076420A CN201110007642A CN102579753A CN 102579753 A CN102579753 A CN 102579753A CN 2011100076420 A CN2011100076420 A CN 2011100076420A CN 201110007642 A CN201110007642 A CN 201110007642A CN 102579753 A CN102579753 A CN 102579753A
- Authority
- CN
- China
- Prior art keywords
- blood
- chinese medicine
- radix
- chinese
- breast carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention belongs to the field of Chinese medicines, in particular to a Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery. The Chinese medicinal composition mainly comprises the following Chinese medicinal components by weight: 20-30g of astragalus, 9-15g of Chinese angelica, 9-15g of prepared rehmannia rhizome, 9-15g of south dodder seed, 9-15g of desertliving cistanche, 9-15g of Chinese yam, 15-20g of indian buead, 15-20g of dried large-head atractylodes rhizome, 6-10g of Chinese thorowax root, 6-10g of dried orange peel and 3-6g of liquoric root. The Chinese medicinal composition has the effects of replenishing qi to invigorate the spleen, warming the yang and tonifying the kidney, and has a definite curative effect on a patient suffering from deficiency of qi and the blood after mammary cancer surgery.
Description
Technical field
The invention belongs to the field of Chinese medicines.
Background technology
Breast carcinoma is a malignant tumor among the whole world women, and have 7.9 ten thousand new cases every year approximately, accounts for whole women's malignant tumor sums 21%.Its morbidity is normal relevant with heredity, and between 40-60 year, menopause front and back women's sickness rate higher.Only the mammary gland patient of about 1-2% is the male.Usually occur in the malignant tumor of breast glandular epithelium tissue.Be one of a kind of women's of having a strong impact on physical and mental health even life-threatening modal malignant tumor, male breast carcinoma is rare.Doctor trained in Western medicine thinks that the generation of breast carcinoma is relevant with following high risk factor: sterile, the fertility number of times is few, first tire term birth evening at age, age of menarche morning, optimum mastopathy history, family history of breast cancer, oral contraceptive, radiation exposure, bad life habits, environmental pollution, viral infection etc.The traditional Chinese medical science thinks that vital QI being weakened and pathogen being violent is total pathogenesis of breast carcinoma morbidity.Positive QI-insufficiency is the main cause that breast carcinoma takes place, and the pathogen invasion then is an essential condition.Healthy energy is deficient, and internal organs are become estranged, imbalance of YIN and YANG, and the heresy of six climate exopathogens is being taken advantage of a weak point in opponent's defence in newborn portion, and meridians are obstructed, and become to the tumor karyomorphism.
Breast carcinoma at present treatment is main with operation, cooperate put, Comprehensive Treatment such as chemotherapy, but put, toxicity that chemotherapy is brought is also very obvious.Chinese medicine breast carcinoma has long history; The Chinese medicine primary disease; Mainly be to carry out further conditioning and treating, not only can disease controlling develop, and can improve recent symptom at the mammary cancer surgery postoperative; To consolidating the state of an illness bigger help is arranged, strengthening the body resistance, eliminating evil, transfer body resistance against diseases, alleviate and effect of crucial importance and unique advantage are arranged aspect the side effect of other treatment.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood, so that provide more medications to select for clinical.
A kind of Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood; Mainly comprise following traditional Chinese medicine components by weight ratio: the Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae; Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.
The women of breast carcinoma postoperative because of major operation consumption impairment of QI blood, has more the performance that the positive at present deficiency of vital energy declines, and reuses Radix Astragali harmonizing the spleen and stomach in the side, and the QI invigorating poison holding not only can the enhancing human body immunity function, and can anticancerly press down cancer.Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI is spleen QI invigorating first key medicine; Rhizoma Dioscoreae spleen reinforcing nourishing the stomach, the lung benefiting the kidney invigorating of promoting the production of body fluid; Poria eliminating dampness by diuresis, spleen invigorating, mind calming; The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen; The Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Poria, Pericarpium Citri Reticulatae etc. help Radix Astragali replenishing QI to invigorate the spleen activating the spleen, help QI and blood, turn round and look to protect the day after tomorrow, make QI and blood biochemistry active, and the vital organs of the human body all receive it.The Chinese angelica blood supplementing regulating menstruation, promoting blood circulation and stopping pain; Radix Rehmanniae Preparata nourishes blood and enriches blood, life essence-filling, marrow-benefitting; Be the key medicine of enriching blood that nourishes blood.The Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI is given birth to and is lifted yang-energy; The old regulating qi-flowing for strengthening spleen of Pericarpium Citri Reticulatae; Radix Bupleuri, the orderly and clearly mechanism of qi of Pericarpium Citri Reticulatae cooperate nourishing blood to suppress the hyperactive liver with the Radix Paeoniae Alba.Semen Cuscutae, Herba Cistanches, Rhizoma Dioscoreae invigorating kidney qi, regulating thoroughfare and controlling vessel, astringency inducing is congenital, makes and is able to balance the congenital day after tomorrow, and healthy energy is full, gets rid of evils and goes out, and prevents or delays the cancerous protuberance relapse and metastasis.The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.
The traditional Chinese medical science had both been considered partial treatment owing to from organic conception, implement determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, taked the method for the body resistance strengthening and constitution consolidating again, all had important effect for the local symptom of improving the patient and overall health of patients.Operation no doubt can be excised cancerous protuberance, but also has in residual cancer or regional lymph node metastasis or the blood vessel cancer embolus existence etc., and the long-term treatment of utilization Chinese medicine postoperative can prevent recurrence and shifts, and can remedy operative treatment, radiotherapy, chemotherapeutical deficiency.Radiotherapy, chemotherapeutic treatment have certain side effect to body, the utilization traditional Chinese medical herbal treatment can alleviate put, the side effect of chemotherapy, can strengthen the effect of radiotherapy, chemotherapy again.
The present invention has replenishing QI to invigorate the spleen, and the merit of temperature male wind-supplying kidney has definite curative effect for the sufferer of breast carcinoma postoperative deficient qi and blood.For the advanced breast cancer patient maybe can not operation and the sufferer of radiotherapy, chemotherapy can adopt traditional Chinese medical herbal treatment, prolong patient's life, improve the quality of living.
The specific embodiment
Example 1
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 2
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.The insomniac adds Fructus Schisandrae Chinensis, Radix Polygalae, each 6~9g of Semen Ziziphi Spinosae, and two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 3
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.Breast side of body breast feeling of distension and oppression pain adds Rhizoma Cyperi, Radix Curcumae, Rhizoma Corydalis, each 9~15g of Rhizoma Chuanxiong, evacuates to transfer to reach, and circulation of qi promoting relieves the pain.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 4
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.The loose stool is more than, watery stool adds Fructus Schisandrae Chinensis 6~9g, astringent therapy antidiarrheal.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Treat breast carcinoma postoperative deficient qi and blood sufferer 22 examples with the present invention.Maximum 66 years old minimum 40 years old average 55.5 years old; With 15 days be a course of treatment, after three courses of treatment, therapeutic outcome: (patient is conscious energetic to cure 6 examples; Activity can necessarily expend bodily strength); Effective 15 examples (the conscious spirit of patient still can weak sx, can carry out general activity), total effective rate 95.45%.Invalid 1 example.Do not see that toxic and side effects takes place.
Claims (4)
1. Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood; It is characterized in that mainly comprising following traditional Chinese medicine components by weight ratio: the Radix Astragali 20~30g; Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae; Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.
2. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Fructus Schisandrae Chinensis, Radix Polygalae, each 6~9g of Semen Ziziphi Spinosae.
3. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Rhizoma Cyperi, Radix Curcumae, Rhizoma Corydalis, each 9~15g of Rhizoma Chuanxiong.
4. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Fructus Schisandrae Chinensis 6~9g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100076420A CN102579753A (en) | 2011-01-14 | 2011-01-14 | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100076420A CN102579753A (en) | 2011-01-14 | 2011-01-14 | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102579753A true CN102579753A (en) | 2012-07-18 |
Family
ID=46469355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100076420A Pending CN102579753A (en) | 2011-01-14 | 2011-01-14 | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579753A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103028090A (en) * | 2012-12-23 | 2013-04-10 | 丁常燕 | Traditional Chinese medicine composition for treating Qi deficiency |
CN103417665A (en) * | 2013-08-12 | 2013-12-04 | 大连大学 | Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation |
CN103690924A (en) * | 2014-01-06 | 2014-04-02 | 河南中医学院 | Traditional Chinese medicine for improving postoperative yin-yang deficiency syndrome of thyroid cancer |
CN105055850A (en) * | 2015-07-30 | 2015-11-18 | 庞群 | Chinese herbal medicament for treating responses to breast cancer radiotherapy and chemotherapy |
CN105362369A (en) * | 2015-11-10 | 2016-03-02 | 首都医科大学附属北京中医医院 | Application of liver soothing and spleen strengthening traditional Chinese medicinal composition in preparing medicine for treating sleep disorder in patients of breast carcinoma |
CN109875033A (en) * | 2019-01-31 | 2019-06-14 | 武汉藻优生物科技有限公司 | A kind of vine tea oral solution suitable for women |
-
2011
- 2011-01-14 CN CN2011100076420A patent/CN102579753A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103028090A (en) * | 2012-12-23 | 2013-04-10 | 丁常燕 | Traditional Chinese medicine composition for treating Qi deficiency |
CN103028090B (en) * | 2012-12-23 | 2014-10-29 | 王新本 | Traditional Chinese medicine composition for treating Qi deficiency |
CN103417665A (en) * | 2013-08-12 | 2013-12-04 | 大连大学 | Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation |
CN103417665B (en) * | 2013-08-12 | 2015-04-01 | 大连大学 | Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation |
CN103690924A (en) * | 2014-01-06 | 2014-04-02 | 河南中医学院 | Traditional Chinese medicine for improving postoperative yin-yang deficiency syndrome of thyroid cancer |
CN103690924B (en) * | 2014-01-06 | 2015-09-30 | 河南中医学院 | A kind of Chinese medicine improving the postoperative deficiency syndrome of both YIN and YANG of thyroid carcinoma |
CN105055850A (en) * | 2015-07-30 | 2015-11-18 | 庞群 | Chinese herbal medicament for treating responses to breast cancer radiotherapy and chemotherapy |
CN105362369A (en) * | 2015-11-10 | 2016-03-02 | 首都医科大学附属北京中医医院 | Application of liver soothing and spleen strengthening traditional Chinese medicinal composition in preparing medicine for treating sleep disorder in patients of breast carcinoma |
CN109875033A (en) * | 2019-01-31 | 2019-06-14 | 武汉藻优生物科技有限公司 | A kind of vine tea oral solution suitable for women |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940721B (en) | Medicine for treating chronic pelvic inflammation | |
CN102512565A (en) | Traditional Chinese medicine composition for treating lumbago due to kidney deficiency | |
CN102872418A (en) | Medicine for treating pelvic inflammation | |
CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
CN102579753A (en) | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery | |
CN102697947A (en) | Traditional Chinese medicine prescription for treating constipation | |
CN103316174A (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
CN102600426B (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
CN103393989A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN104721792A (en) | Traditional Chinese medicine composition for treating intolerance of cold | |
CN103721230A (en) | Traditional Chinese medicinal composition for treating liver cancer | |
CN101313952A (en) | Traditional Chinese herb medicine for treating cancer | |
CN103127294A (en) | Traditional Chinese medicine composition for treating chronic nephritis | |
CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
CN101422547B (en) | Traditional Chinese medicine for treating kidney-deficiency blood-insufficiency type amenorrhea | |
CN102397438A (en) | Medicine for treating low renal function | |
CN101721669A (en) | Traditional Chinese medicine composition for treating cold dampness type sciatica | |
CN102343009B (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat | |
CN101091764A (en) | Composition of Chinese traditional medicine for treating chronic nephritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120718 |